Discover 376 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 376
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
for
Growth Hormone Deficiency
Location: Norfolk VA, Washington D.C. DC, Morristown NJ,
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Norfolk VA, Richmond VA, Chapel Hill NC, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase3, Recruiting
Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Norfolk VA, Greenville SC, Kettering OH, Yakima WA,
Sponsor: Cylene Pharmaceuticals
Sex: All
Age: 18+
Code: NCT01199718
Phase1, Recruiting
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
for
Neoplasms
Location: Norfolk VA, Myrtle Beach SC, New Brunswick NJ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06551142
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Norfolk VA, Newport News VA, Raleigh NC, Pikesville MD,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Norfolk VA, Morehead City NC, Manassas VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase3, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Norfolk VA, Newport News VA, Raleigh NC, Pikesville MD,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase3, Recruiting
Home OCT Fluid Visualization Agreement Study
for
Neovascular Age-related Macular Degeneration
Location: Norfolk VA, Richmond VA, Glen Burnie MD, Lexington KY,
Sponsor: Notal Vision Inc.
Sex: All
Age: 55+
Code: NCT04907409
Recruiting
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Norfolk VA, Boston MA, Katy TX
Sponsor: Skyline Therapeutics (US) Inc.
Sex: All
Age: 50+
Code: NCT05986864
Phase1, Phase2, Recruiting
Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT
for
Diabetic Macular Edema
Location: Norfolk VA, Fairfax VA, Baltimore MD
Sponsor: Notal Vision Inc.
Sex: All
Age: 0+
Code: NCT05745116
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Norfolk VA, Wake Forest NC, Durham NC, Chevy Chase MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase2, Phase3, Recruiting
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Norfolk VA, Durham NC, Myrtle Beach SC,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT06800313
Phase1, Phase2, Recruiting
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
for
Atopic Dermatitis
Location: Norfolk VA, Rockville MD, Morgantown WV, Portsmouth NH,
Sponsor: Castle Biosciences Incorporated
Sex: All
Age: 12 - 70+
Code: NCT07645820
Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
for
Hypertension, Uncontrolled Hypertension
Location: Norfolk VA, Kinston NC, Burke VA, Charleston SC,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07090161
Phase2, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata